Related Experiment Videos
[Novel biological response modifiers: phthalimides with TNF-alpha production regulating activity]
H Miyachi1, A Azuma, Y Hashimoto
1Institute of Molecular and Cellular Biosciences, University of Tokyo, Japan.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|February 1, 1997
Summary
Thalidomide and related compounds exhibit dual effects on tumor necrosis factor alpha (TNF-alpha) production, acting as both enhancers and inhibitors depending on the cell type and stimulus. This differential regulation suggests distinct molecular targets for therapeutic applications.
Area of Science:
- Immunology
- Pharmacology
Context:
- Tumor necrosis factor alpha (TNF-alpha) is a key cytokine with dual roles in immunity, beneficial in normal function but damaging in excess.
- Thalidomide, a drug with a complex history, is known to inhibit TNF-alpha production and is explored for treating immune disorders.
Purpose:
- To investigate the specific mechanisms by which thalidomide and its analogues regulate TNF-alpha production.
- To determine if the regulation of TNF-alpha production is specific to the inducer and cell type.
Summary:
- Thalidomide and related phthalimides demonstrate inducer-specific and cell-type-specific regulation of TNF-alpha production.
- These compounds enhance TNF-alpha production in HL-60 cells stimulated by TPA but inhibit it in THP-1 cells under the same conditions.
- Conversely, they inhibit TNF-alpha production in both cell types when stimulated by okadaic acid.
Impact:
- The findings suggest that the distinct regulatory effects of thalidomide derivatives imply different molecular targets for modulating TNF-alpha.
- This research opens avenues for developing targeted biological response modifiers (BRMs) based on the specific immune context.